2005 logo

SSY Group Limited Stock Price

SEHK:2005 Community·HK$8.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

2005 Share Price Performance

HK$0
-3.49 (-100.00%)
HK$0
-3.49 (-100.00%)
Price HK$0

2005 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with adequate balance sheet.

2 Risks
2 Rewards

SSY Group Limited Key Details

HK$4.6b

Revenue

HK$2.6b

Cost of Revenue

HK$2.0b

Gross Profit

HK$1.3b

Other Expenses

HK$658.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.23
42.68%
14.38%
52.9%
View Full Analysis

About 2005

Founded
1999
Employees
5700
CEO
Jiguang Qu
WebsiteView website
www.ssygroup.com.hk

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.

Recent 2005 News & Updates

Recent updates

No updates